Canonical metabolic pathways | P-Value | No of genes |
---|---|---|
LEC | Â | Â |
Oxidative Phosphorylation | 4.52E-17 | 29 |
Ubiquinone biosynthesis | 8.04E-12 | 14 |
Purine metabolism | 0.00166 | 18 |
Pyrimidine metabolism | 0.0274 | 9 |
Limbus | Â | Â |
Pentose Phosphate Pathway | 0.0014 | 5 |
Oxidative Phosphorylation | 0.00795 | 7 |
Valine, Leucine and Isoleucine Biosynthesis | 0.00851 | 2 |
Alanine and aspartate metabolism | 0.0151 | 3 |
Glycolysis/gluconeogenesis | 0.047 | 4 |
Cornea | Â | Â |
Oxidative Phosphorylation | 3.48E-21 | 41 |
Ubiquinone Biosynthesis | 2.14E-08 | 16 |
Purine metabolism | 0.000118 | 30 |
Alanine and Aspartate metabolism | 0.000869 | 9 |
Glutathione metabolism | 0.00607 | 8 |
Glycolysis/gluconeogenesis | 0.00855 | 12 |
Lysine biosynthesis | 0.0402 | 2 |
Citrate cycle | 0.042 | 4 |
Pyruvate metabolism | 0.0451 | 8 |
Canonical Signaling Pathways | Â | Â |
LEC | Â | Â |
NRF2-mediated Oxidative Stress Response | 2.29E-05 | 16 |
Nucleotide Excision Repair Pathway | 3.17E-05 | 7 |
Protein Ubiquitination Pathway | 2.06E-05 | 16 |
Estrogen Receptor Signaling | 8.79E-03 | 8 |
Glucocorticoid Receptor Signaling | 1.81E-02 | 13 |
Limbus | Â | Â |
NRF2-mediated Oxidative Stress Response | 2.81E-02 | 7 |
Regulation of actin based motility by Rho | 4.51E-02 | 4 |
Cornea | Â | Â |
NRF2 mediated Oxidative Stress Response | 2.51E-04 | 21 |
Protein Ubiquitination Pathway | 3.09E-07 | 26 |
Estrogen Receptor Signaling | 3.67E-04 | 15 |
Antigen Presentation Pathway | 1.29E-03 | 7 |
VDR/RXR Activation | 6.31E-03 | 10 |
Glucocorticoid Receptor Signaling | 3.05E-02 | 20 |
Nucleotide Excision repair | 2.77E-04 | 8 |